Aflac Gears Up for Q2 Earnings: Ready to Quack or Set to Crack?

01.08.25 15:26 Uhr

Werte in diesem Artikel
Aktien

91,38 EUR -1,20 EUR -1,30%

70,50 EUR 1,00 EUR 1,44%

Indizes

6.664,4 PKT 32,4 PKT 0,49%

PKT PKT

Insurance provider Aflac Incorporated AFL is set to report its second-quarter 2025 results on Aug. 5, 2025, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $1.71 per shareon revenues of $4.43 billion.The second-quarter earnings estimate declined by 2 cents over the past 60 days. The bottom-line projection indicates a year-over-year decline of 6.6%. Also, the Zacks Consensus Estimate for quarterly revenues suggests a year-over-year decrease of 13.7%. Image Source: Zacks Investment ResearchFor full-year 2025, the Zacks Consensus Estimate for Aflac’s revenues is pegged at $17.68 billion, implying a fall of 0.9% year over year. Also, the consensus mark for 2025 EPS is pegged at $6.75, implying a 6.4% year-over-year decline.Aflac beat earnings estimates in two of the past four quarters and missed twice, with the average surprise being 9.3%. This is depicted in the figure below.Aflac Incorporated Price and EPS Surprise Aflac Incorporated price-eps-surprise | Aflac Incorporated QuoteQ2 Earnings Whispers for AflacOur proven model does not conclusively predict an earnings beat for the company this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. That’s not the case here.AFL has an Earnings ESP of -1.25% and a Zacks Rank #2. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.You can see the complete list of today’s Zacks #1 Rank stocks here.What’s Shaping Aflac’s Q2 Results?The Zacks Consensus Estimate for second-quarter total net earned premiums indicates a 3.4% year-over-year increase. While the consensus mark signals a 3.3% increase in total adjusted revenues in the Aflac U.S. unit, due to higher premiums, the same for the Aflac Japan unit predicts a 2.6% fall from the year-ago quarter.The consensus mark for net investment income predicts a 17.2% decline from the year-ago period. Total benefit to premium ratio in Aflac U.S. is pegged at 47.8, up from 46.7 a year ago. Yet, the same for Aflac Japan stands at 65.3, down from 66.9 in the year-ago period.The Zacks Consensus Estimate for pre-tax adjusted earnings from Aflac U.S. indicates an 8.1% year-over-year fall. Similarly, Aflac Japan is likely to have witnessed a 13.2% decline in pre-tax adjusted earnings.The factors stated above are likely to have positioned Aflac for year-over-year declines, making an earnings beat uncertain. The negatives are likely to have been partly offset by significantly improved pre-tax adjusted earnings figures from Corporate and other.How Did Aflac’s Peers Perform?Several insurance companies, including Marsh & McLennan Companies, Inc. MMC, Aon plc AON and AMERISAFE, Inc. AMSF, have already reported their financial results for the June quarter of 2025. Here’s how they had performed:Marsh & McLennan reported second-quarter 2025 adjusted earnings per share of $2.72, which surpassed the Zacks Consensus Estimate by 2.3%, aided by strong growth in Risk and Insurance Services, particularly from the Marsh and Guy Carpenter businesses. However, the upside was partly offset by Marsh & McLennan’s elevated operating expenses, primarily due to increased compensation and benefits.AON reported second-quarter adjusted earnings of $3.49 per share, which beat the Zacks Consensus Estimate by 2.7%, benefiting from new business growth and solid retention rates in its solution lines. AON’s Risk Capital and Human Capital segments gained from organic revenue growth, NFP acquisition synergies and net restructuring savings. However, the upside was partially offset by escalating operating costs.AMERISAFE reported second-quarter adjusted earnings per share of 53 cents, which missed the Zacks Consensus Estimate by 3.6%, affected by a drop in net investment income, softer underwriting results and elevated expense levels. AMSF’s strong retention rates and new business growth partially offset the negatives.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Aflac Incorporated (AFL): Free Stock Analysis Report AMERISAFE, Inc. (AMSF): Free Stock Analysis Report Marsh & McLennan Companies, Inc. (MMC): Free Stock Analysis Report Aon plc (AON): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Aflac und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Aflac

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Aflac

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Aflac Inc

Wer­bung

Analysen zu Aflac Inc

DatumRatingAnalyst
21.03.2018Aflac Equal WeightBarclays Capital
03.07.2017Aflac Equal WeightBarclays Capital
01.05.2017Aflac UnderperformRBC Capital Markets
02.02.2017Aflac UnderperformRBC Capital Markets
09.12.2016Aflac UnderperformRBC Capital Markets
DatumRatingAnalyst
16.05.2012Aflac outperformRBC Capital Markets
14.05.2012Aflac overweightBarclays Capital
27.04.2012Aflac sector outperformScotia Capital Markets
26.04.2012Aflac outperformRBC Capital Markets
27.03.2012Aflac overweightBarclays Capital
DatumRatingAnalyst
21.03.2018Aflac Equal WeightBarclays Capital
03.07.2017Aflac Equal WeightBarclays Capital
10.05.2016Aflac Mkt PerformFBR Capital
27.04.2016Aflac NeutralUBS AG
27.04.2016Aflac Sector PerformRBC Capital Markets
DatumRatingAnalyst
01.05.2017Aflac UnderperformRBC Capital Markets
02.02.2017Aflac UnderperformRBC Capital Markets
09.12.2016Aflac UnderperformRBC Capital Markets
09.01.2012Aflac sellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Aflac Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen